Market Research Report - 243847
United States Markets for Instrumented Spinal Fusion and Posterior Dynamic Stabilization Products
|Published by||Medtech Insight|
|Published||Content info||167 pages|
|United States Markets for Instrumented Spinal Fusion and Posterior Dynamic Stabilization Products|
|Published: June 7, 2012||Content info: 167 pages||
The growing number of older people living in the United States (U.S.) with age-related degenerative disorders of the spine will continue to play a large part in driving the demand for spinal fusion and posterior dynamic stabilization procedures. It is projected that between the years 2010 and 2020, the population in the U.S. age 65 and older will increase 8.6%, from 309.2 million to 336.0 million.
Instrumented spinal fusion and posterior dynamic stabilization procedures generated an estimated $2,403.2 million in corresponding product sales in the U.S. in 2011. It is expected that during the forecast period covered by this report, sales of instrumented spinal fusion and posterior dynamic stabilization implants in the U.S. will increase at a compound annual rate of 3.0%, reaching an estimated $2,790.0 million in the year 2016.
This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities for suppliers of instrumented spinal fusion and posterior dynamic stabilization products to the U.S.
This report includes an overview of spinal disorders and available treatment options as well as an analysis of the U.S. markets for spinal fusion instrumentation products (including anterior column plating systems, interbody fusion devices, and posterior spinal fixation implants) and posterior dynamic stabilization products (including interspinous process spacers, pedicle screw systems, and facet replacement technologies).
Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.